Last Applicant/ Owned by
OYSTER POINT PHARMA INC.
202 Carnegie Center, Suite 109Princeton NJ 08540
US
Serial Number
2071749 filed on 14th Nov 2020
Registration Number
TMA1128575 registered on 11th May 2022
Registration expiry Date
14th Nov 2030Correspondent Address
SMART & BIGGAR LP
1100-150 York StreetToronto
ONTARIO
CA
M5H3S5
Trademark usage description
pharmaceutical preparations for the treatment of dry eye disease; pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutic Read More11
2071749
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 26 on 19th Jan 2022 | Approved |
Submitted for opposition 27 on 19th Jan 2022 | Approval Notice Sent |
Submitted for opposition 22 on 13th Jan 2022 | Search Recorded |
Submitted for opposition 256 on 18th Oct 2021 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 2th Mar 2021 | Agent Changed |
Submitted for opposition 257 on 17th Dec 2020 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 16th Dec 2020 | Created |
Submitted for opposition 31 on 16th Dec 2020 | Formalized |
Submitted for opposition 30 on 14th Nov 2020 | Filed |
Submitted for opposition 228 on 14th Nov 2020 | International Registration |